Otorrhea Clinical Trial
Verified date | January 2012 |
Source | Alcon Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Observational |
This study was conducted to describe the time to first incidence of otorrhea post tympanostomy tube insertion.
Status | Terminated |
Enrollment | 1389 |
Est. completion date | November 2011 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 6 Months to 12 Years |
Eligibility |
Inclusion Criteria: - Participants must be at least 6 months old and no more than 13 years of age at the time of enrollment scheduled for unilateral or bilateral myringotomy and tympanostomy tube insertion. Patients and/or child must read/sign informed consent and comply with requirement of the study. Exclusion Criteria: - There are no exclusion criteria. |
N/A
Country | Name | City | State |
---|---|---|---|
United States | Contact Alcon Call Center for Trial Locations | Fort Worth | Texas |
Lead Sponsor | Collaborator |
---|---|
Alcon Research |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of, time to, and relationship of risk factors associated with otorrhea post tympanostomy tube insertion. | Up to 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03347461 -
Otiprio Versus Ciprodex Tympanostomy Tube Outcomes
|
Phase 4 | |
Recruiting |
NCT04807660 -
Bacteriological Evaluation of Children With Otorrhea
|
||
Withdrawn |
NCT00956748 -
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
|
Phase 4 | |
Terminated |
NCT02817347 -
A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea
|
Phase 1/Phase 2 |